Toward a national health policy: Public policy and the control of health care costs

1978 ◽  
Vol 12 ◽  
pp. 62-63
Author(s):  
Eric B. Larson
Author(s):  
Alex Rajczi

Most Americans see the need for a national health policy that guarantees reasonable access to health insurance for all citizens, but some worry that a universal health insurance system would be inefficient, create excessive fiscal risk, or demand too much of them, either by increasing their taxes or by rendering their own health insurance unaffordable. After describing these three objections and the role they play in health care debates, the introduction outlines the contents of each chapter. It concludes with some remarks about how data will be handled in the book’s later chapters.


Author(s):  
Igor A Zupanets ◽  
Victoriia Ye Dobrova ◽  
Olena O Shilkina

Objective: The objective of this research was to formulate the theoretical approaches to the improvement of pharmaceutical care considering the modern requirements of the public health system in Ukraine.Methods: The analysis of pharmaceutical care has been performed using “policy triangle” model. The pharmaceutical care policy model has been developed by applying the process approach.Results: The model of pharmaceutical care as a structural element of the national health policy has been developed. This model describes mechanisms by which the content, context, and process of the pharmaceutical care policy are influenced by the content, context, and process of the national health policy. Furthermore, we have defined the actors of the pharmaceutical care policy which are groups and organizations of various levels involved in the formation and development of the pharmaceutical care policy. Then, the structure of the pharmaceutical care policy has been elaborated. This policy is integrated into the national health-care system and is adapted to the good pharmacy practice requirements. The center of the policy is a process of pharmaceutical care delivering. The inputs, outcomes, management, and resources that are required for the pharmaceutical care process and provided by the actors have been identified. The data streams within this structure demonstrate implementation of the key elements of the pharmaceutical care process: Patient involvement, patient counseling and education, interprofessional collaboration, documentation of interaction, and follow-up. Furthermore, the mechanism of continual education and increasing of the professional level has been described in this structure.Conclusion: Proposed framework provides a comprehensive view of pharmaceutical care as a structural element of the national health policy considering new trends of the Ukrainian health system. The proposed model of the pharmaceutical care policy allows policy-makers to address all critical-to-quality aspects and stakeholders’ needs.


2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 855-855
Author(s):  
Julie Robison

Abstract The risk of death, disease, disability, hospitalization, institutionalization and high health care costs varies among individuals with increasing heterogeneity associated with aging. Frailty, physical performance measures, self-reported measures and multimorbidity all represent measures that are useful in helping to better define such heterogeneity at the level of populations and to ultimately define such risk in individuals. These higher risk individuals account for a growing proportion of this nation’s health care costs, with continued increases over time that appear unsustainable in the long term. Therefore, efforts to better define the nature of such heterogeneity of risk and improved targeting, with the goals of improving outcomes and reducing costs, are essential. A closely related challenge is to effectively translate proven clinical and health system interventions from the world of research to that of health policy and real-world clinical practice via pragmatic trials.


2017 ◽  
Vol 105 ◽  
pp. 71-84
Author(s):  
Paweł Lenio

ADJOURNMENT OF REFUND OF HEALTH CARE COSTS IN THE LIGHT OF THE CROSS-BORDER HEALTH CARE DIRECTIVEThis paper outlines the possibility of adjournment of health care costs refund in the light of the cross-border health care directive. The main purpose of this paper is to determine whether cross-border health care Directive has been correctly implemented in the national law. The Directive permits adjournment of refund of cross-border health care costs. It seems that the Directive is not properly implemented into the polish law. The controversy surrounds the act of tying reimbursements to a strict budget in the National Health Fund.


2019 ◽  
Vol 17 (3) ◽  
pp. 659-677
Author(s):  
Jana Rozmarinová

The article deals with strategic documents created at the regional level in the context of their relevance to the implementation of the national health policy and their relevance to the solution of the inequalities among regions in access to primary care. The aim of this contribution is to map and evaluate the activity of regions in terms of their conceptual activities related to the establishment of regional policy objectives for the 2010-2015 period. The implementation of the national health policy (i.e. the “Health 21” and “Health 2020” programs) is examined in the context of the regional conceptual activities. The obtained results show that the conceptual activities of regions in the area related to health care differ significantly. While some regional development programs devote only a few pages to healthcare issues, other regions create comprehensive concepts of health care. With the measurement of inequalities, we indicate the regions that are underserved with healthcare services, of which only the Ústí nad Labem region shows the plan to dealt with this disadvantage in its strategic health plan. 


Sign in / Sign up

Export Citation Format

Share Document